Aug 2026· Acta Tropica· Vol 282, pp.
108279
· 1 citation· 38 references
Medicine
TL;DR
This study identifies L-lysine depletion as a metabolic feature of T. gondii infection and demonstrates that its supplementation confers measurable host-protective benefits, and supports the concept of L-lysine supplementation as a host-directed adjunctive intervention to mitigate pathology during toxoplasmosis.
Abstract
Toxoplasmosis is a widespread zoonotic disease causing severe outcomes in immunocompromised individuals and during pregnancy. Current therapeutic options target actively replicating stages of the parasite and show limited efficacy against chronic infection. While research has focused on parasite-directed therapies, host-directed strategies to enhance tolerance and preserve tissue integrity remain underexplored. In this study, we analyzed untargeted serum metabolomics data to identify host metabolic alterations during acute and chronic Toxoplasma gondii (T. gondii) infection in a murine model. Analysis of metabolomic data revealed widespread infection-associated metabolic remodeling, with consistent perturbations in lipid metabolism and amino acid pathways. Among the metabolites most robustly depleted during infection was the essential amino acid L-lysine. We evaluated the impact of L-lysine supplementation on disease outcomes in vivo. L-lysine supplementation was associated with a trend toward improved survival and reduced tissue pathology during both acute and chronic infection. Supplemented mice also exhibited reduced inflammatory cytokine dysregulation and lower tissue parasite burdens, effects that are consistent with enhanced host resilience rather than direct antiparasitic activity. These findings identify L-lysine depletion as a metabolic feature of T. gondii infection and demonstrate that its supplementation confers measurable host-protective benefits. Our study highlights the value of metabolomics-guided approaches for uncovering host metabolic vulnerabilities and supports the concept of L-lysine supplementation as a host-directed adjunctive intervention to mitigate pathology during toxoplasmosis.
Influenza virus infection remains a leading cause of acute respiratory illness worldwide, with increasing resistance to conventional antiviral therapies highlighting the need for novel therapeutic strategies. This review introduces the concept of metabolizeaccretion, a self-reinforcing pathological cascade driven by me...
Ke-Xin Wang, Yue-Peng Li, Xiao-Hong Chen et al.· Pharmacology and Therapeutic...· 0 citations
The results unveil the importance of LDs and glycerolipid metabolism for WNV and highlight the potential of therapeutic interventions targeting this pathway to control viral replication and neuroinflammation.
F. Caridi, Patricia Mingo-Casas, Ana Esteban et al.· Emerging Microbes and Infect...· 0 citations
Lyme neuroborreliosis (LNB), caused by Borrelia garinii, often leads to persistent neurological deficits, yet early diagnosis remains insensitive and the temporal metabolic changes in the infected brain are largely unexplored. In this study, a murine model of B. garinii infection was established using 80 female BALB/c...
Bin-Tao Zhai, Q. Niu, Hui Yang et al.· Biomolecules· 0 citations
Viral infection of the central nervous system (CNS) is increasingly linked to neurodegenerative disease, yet the metabolic programs that shape antiviral immunity and neuroinflammation remain poorly defined. Nicotinamide adenine dinucleotide (NAD) regulates mitochondrial function and immune signaling, and supplement...
Cong Thanh Nguyen, F. Sato, Seiichi Omura et al.· Scientific Reports· 0 citations
The findings provide a novel metabolic perspective on the intestinal pathogenesis of toxoplasmosis and offer exploratory candidate lipid markers for diagnosing acute infection.
Wen-Jie Cheng, Bo-Fang Duan, Cai-Qin Deng et al.· Microorganisms· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.